Xlife Sciences AG (SWX:XLS)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
22.50
-0.80 (-3.43%)
Last updated: Dec 5, 2025, 2:09 PM CET
-14.45%
Market Cap 129.77M
Revenue (ttm) 839.38K
Net Income (ttm) 30.75M
Shares Out 5.77M
EPS (ttm) 4.54
PE Ratio 4.95
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 17,487
Average Volume 5,512
Open 23.50
Previous Close 23.30
Day's Range 22.50 - 24.70
52-Week Range 15.75 - 28.90
Beta 0.27
RSI 73.64
Earnings Date Apr 28, 2026

About Xlife Sciences AG

Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company’s project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical resea... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 17
Stock Exchange SIX Swiss Exchange
Ticker Symbol XLS
Full Company Profile

Financial Performance

In 2024, Xlife Sciences AG's revenue was 834,877, a decrease of -15.54% compared to the previous year's 988,435. Earnings were 34.28 million, an increase of 130.37%.

Financial Statements

News

There is no news available yet.